Quantified Imaging
Quantified Imaging is developing ground-breaking diagnostic tools for dementia and traumatic brain injury based on non-contrast perfusion MRI. The company aims to deliver accurate, scalable, and cost-effective brain health imaging solutions that support early diagnosis, disease monitoring, and clinical trials. They are actively seeking clinical collaborations and are involved in various research, development, and commercial activities to advance MRI technology for brain health.
Industries
Nr. of Employees
small (1-50)
Products
Vendor-agnostic ASL post-processing platform
A platform-agnostic ASL post-processing software that produces CBF and ATT maps, demographic Z-scores, automated QC, harmonisation, surface analysis, image deblurring and automated regional biomarker reports for clinical and trial use.
Vendor-agnostic ASL post-processing platform
A platform-agnostic ASL post-processing software that produces CBF and ATT maps, demographic Z-scores, automated QC, harmonisation, surface analysis, image deblurring and automated regional biomarker reports for clinical and trial use.
Services
Processing and reporting service that converts ASL acquisitions into CBF/ATT maps, demographically corrected Z-scores, automated QC flags and longitudinal summaries for clinical use.
End-to-end ASL processing pipeline for clinical trials providing harmonisation, normative modelling, surface-based analysis, automated QC and standardized perfusion metrics across sites and sequences.
Processing and reporting service that converts ASL acquisitions into CBF/ATT maps, demographically corrected Z-scores, automated QC flags and longitudinal summaries for clinical use.
End-to-end ASL processing pipeline for clinical trials providing harmonisation, normative modelling, surface-based analysis, automated QC and standardized perfusion metrics across sites and sequences.
Expertise Areas
- Perfusion MRI quantification
- Clinical imaging reporting (neuro)
- Clinical trials imaging and imaging biomarkers
- Normative modelling and individual abnormality detection
Key Technologies
- Arterial spin labelling (ASL) MRI
- Bayesian / variational inference
- Surface-based image analysis
- Partial-volume correction
News & Updates
Quantified Imaging has been selected to join the prestigious health tech accelerator run by Plug and Play VC in collaboration with the West Midlands Health Tech authority.
Quantified Imaging has signed its first commercial agreement with mediri GmbH to work on blood-brain barrier (BBB) ASL imaging for clinical trials.
QI’s CEO, Tom Kirk, was invited to represent Quantified Imaging at the launch of the next stage of the Barbara Windsor Dementia Mission at Downing Street.
Quantified Imaging has been awarded an Innovate UK SBRI contract to develop dementia imaging biomarkers using ASL MRI technology.
Quantified Imaging has been awarded a BBSRC ICURe follow-on funding award from Innovate UK to commercialise the ASL MRI quantification tools.
Quantified Imaging has been selected to join the prestigious health tech accelerator run by Plug and Play VC in collaboration with the West Midlands Health Tech authority.
Quantified Imaging has signed its first commercial agreement with mediri GmbH to work on blood-brain barrier (BBB) ASL imaging for clinical trials.
QI’s CEO, Tom Kirk, was invited to represent Quantified Imaging at the launch of the next stage of the Barbara Windsor Dementia Mission at Downing Street.
Quantified Imaging has been awarded an Innovate UK SBRI contract to develop dementia imaging biomarkers using ASL MRI technology.
Quantified Imaging has been awarded a BBSRC ICURe follow-on funding award from Innovate UK to commercialise the ASL MRI quantification tools.